While previous studies have established KLF5’s context-dependent roles—functioning as a potent oncogene in carcinomas such as colorectal (19), yet exhibiting tumor-suppressive properties in specific contexts like breast cancer and prostate cancer (22, 24, 25, 45)—these fragmented findings necessitate a holistic reinterpretation. This evidence concerns the gene KLF5 and prostate carcinoma.